LegoChem Biosciences, Inc. (141080.KQ)

KRW 96700.0

(-6.84%)

Revenue Summary of LegoChem Biosciences, Inc.

LegoChem Biosciences, Inc.'s latest annual revenue in 2023 was 34.14 Billion KRW , up 2.2% from previous year.
LegoChem Biosciences, Inc.'s latest quarterly revenue in 2024 Q2 was 30.75 Billion KRW , down -0.97% from previous quarter.
LegoChem Biosciences, Inc. reported a annual revenue of 33.41 Billion KRW in annual revenue 2022, up 3.9% from previous year.
LegoChem Biosciences, Inc. reported a annual revenue of 32.15 Billion KRW in annual revenue 2021, down -34.9% from previous year.
LegoChem Biosciences, Inc. reported a quarterly revenue of 31.05 Billion KRW for 2024 Q1, up 238.02% from previous quarter.
LegoChem Biosciences, Inc. reported a quarterly revenue of 7.65 Billion KRW for 2023 Q1, down -19.49% from previous quarter.

Annual Revenue Chart of LegoChem Biosciences, Inc. (2023 - 2016)

Historical Annual Revenue of LegoChem Biosciences, Inc. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	34.14 Billion KRW	2.2%
2022	33.41 Billion KRW	3.9%
2021	32.15 Billion KRW	-34.9%
2020	49.39 Billion KRW	-14.1%
2019	57.5 Billion KRW	127.81%
2018	25.24 Billion KRW	14.43%
2017	22.05 Billion KRW	32.43%
2016	16.65 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q2	30.75 Billion KRW	-0.97%
2024 Q1	31.05 Billion KRW	238.02%
2023 Q1	7.65 Billion KRW	-19.49%
2023 Q2	12.08 Billion KRW	57.76%
2023 Q3	5.21 Billion KRW	-56.8%
2023 Q4	9.18 Billion KRW	76.05%
2023 FY	34.14 Billion KRW	2.2%
2022 Q1	5.8 Billion KRW	-67.54%
2022 FY	33.41 Billion KRW	3.9%
2022 Q3	6.39 Billion KRW	-45.39%
2022 Q2	11.7 Billion KRW	101.64%
2022 Q4	9.51 Billion KRW	48.83%
2021 FY	32.15 Billion KRW	-34.9%
2021 Q3	4.39 Billion KRW	0.0%
2021 Q4	17.88 Billion KRW	306.68%
2020 FY	49.39 Billion KRW	-14.1%
2019 FY	57.5 Billion KRW	127.81%
2018 FY	25.24 Billion KRW	14.43%
2017 FY	22.05 Billion KRW	32.43%
2016 FY	16.65 Billion KRW	0.0%

Peer Revenue Comparison of LegoChem Biosciences, Inc.

Name	Revenue	Revenue Difference
HLB Co., Ltd.	42.9 Billion KRW	20.407%
iNtRON Biotechnology, Inc.	9.58 Billion KRW	-256.224%
BINEX Co., Ltd.	154.82 Billion KRW	77.946%
Bioneer Corporation	263.23 Billion KRW	87.029%
Anterogen.Co.,Ltd.	6.5 Billion KRW	-425.297%
MEDIPOST Co., Ltd.	68.64 Billion KRW	50.256%
CrystalGenomics, Inc.	4.87 Billion KRW	-599.897%
Helixmith Co., Ltd	4.2 Billion KRW	-712.677%
Chabiotech Co.,Ltd.	953.95 Billion KRW	96.421%
Medy-Tox Inc.	221.12 Billion KRW	84.558%
Peptron, Inc.	3.34 Billion KRW	-921.745%
Amicogen, Inc.	159.9 Billion KRW	78.646%
Genexine, Inc.	4.42 Billion KRW	-671.369%
HLB Therapeutics Co.,Ltd.	53.74 Billion KRW	36.472%
ALTEOGEN Inc.	96.52 Billion KRW	64.624%
PharmaResearch Co., Ltd.	261.01 Billion KRW	86.918%
SillaJen, Inc.	3.93 Billion KRW	-766.738%
JETEMA, Co., Ltd.	58.71 Billion KRW	41.846%
OliX Pharmaceuticals,Inc	17.06 Billion KRW	-100.1%
Genomictree Inc.	3.41 Billion KRW	-898.992%
MedPacto, Inc.	- KRW	-Infinity%
D&D Pharmatech	18.67 Billion KRW	-82.821%
EASY BIO,Inc.	165.38 Billion KRW	79.354%
GI Innovation, Inc.	5.31 Billion KRW	-541.974%